Serum sickness following rituximab therapy in a patient with pemphigus vulgaris: A case report

Serum sickness, a reaction presenting with a classic triad (fever, rash, myalgia/arthralgia), is considered as a rare adverse event following monoclonal antibodies and specifically following treatment with rituximab. This report describes a case of serum sickness in a newly treated young male patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Khatib, Mohamad Y., Allafi, Solaiman M., Nashwan, Abdulqadir J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869366/
https://www.ncbi.nlm.nih.gov/pubmed/33598239
http://dx.doi.org/10.1002/ccr3.3642
Descripción
Sumario:Serum sickness, a reaction presenting with a classic triad (fever, rash, myalgia/arthralgia), is considered as a rare adverse event following monoclonal antibodies and specifically following treatment with rituximab. This report describes a case of serum sickness in a newly treated young male patient with rituximab for pemphigus vulgaris.

Ejemplares similares